> It's easier and cheaper to test new drugs outside the us/eu because laxer regulations.
Given your comments elsewhere I suspect you're claiming this with no evidence.
For other readers, this isn't true / it's drug dependent. Amongst other things: difficulty sourcing the correct patients; difficulty importing drugs, particularly because they're not yet approved; difficulty getting high quality or reliable labs; etc. As any ctm could have told you.
As for this drug: the US/EU don't have rampant hiv, esp with the use of PrEP.
Given your comments elsewhere I suspect you're claiming this with no evidence.
For other readers, this isn't true / it's drug dependent. Amongst other things: difficulty sourcing the correct patients; difficulty importing drugs, particularly because they're not yet approved; difficulty getting high quality or reliable labs; etc. As any ctm could have told you.
As for this drug: the US/EU don't have rampant hiv, esp with the use of PrEP.